Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Integra LifeSciences Corporation
With
Beth Israel Deaconess Medical Center
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult Type 1 or 2 diabetic patients that present with foot ulcers.
Ulcer size of at least 3 centimeters (cm) in diameter at its widest dimension.
Ulcer depth: Full thickness (absence of all epithelial layers or deeper)
Adequate perfusion (at least one palpable pedal pulse or pedal bypass graft)
All ulcer durations will be eligible
Patients currently receiving NPWT for a diabetic foot ulcer
Patients must be appropriate NPWT candidates and be willing and able to sleep, ambulate, and rest with the NPWT unit in place.
You may not be if
Active foot infections
Presence of any serious disease including end-stage renal failure requiring dialysis or renal transplantation or active malignant disease requiring treatment which seriously compromises the patient's ability to complete this study
Patients who are pregnant
Allergies to any material contained within the NPWT or bioscaffold
Any condition that would exclude NPWT use including but not limited to active bleeding, presence of malignancy in the wound or inability to follow any of the NPWT safety guidelines